ZA200805385B - Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases - Google Patents

Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases

Info

Publication number
ZA200805385B
ZA200805385B ZA200805385A ZA200805385A ZA200805385B ZA 200805385 B ZA200805385 B ZA 200805385B ZA 200805385 A ZA200805385 A ZA 200805385A ZA 200805385 A ZA200805385 A ZA 200805385A ZA 200805385 B ZA200805385 B ZA 200805385B
Authority
ZA
South Africa
Prior art keywords
novel
cardiovascular diseases
treating cardiovascular
acyclic substituted
furopyrimidine derivatives
Prior art date
Application number
ZA200805385A
Other languages
English (en)
Inventor
Lampe Thomas
Becker Eva-Maria
Kast Raimund
Beck Hartmut
Jeske Mario
Schuhmacher Joachim
Stoll Friederike
Klein Martina
Akbaba Metin
Knorr Andreas
Stasch Johannes-Peter
Baerfacker Lars
Hillisch Alexander
Karig Gunter
Meininghaus Mark
Schlemmer Karl-Heinz
Schohe-Loop Rudolf
Original Assignee
Bayer Schreing Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schreing Pharma Ag filed Critical Bayer Schreing Pharma Ag
Publication of ZA200805385B publication Critical patent/ZA200805385B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200805385A 2005-12-21 2008-06-20 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases ZA200805385B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005061170A DE102005061170A1 (de) 2005-12-21 2005-12-21 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung

Publications (1)

Publication Number Publication Date
ZA200805385B true ZA200805385B (en) 2009-10-28

Family

ID=37876878

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805385A ZA200805385B (en) 2005-12-21 2008-06-20 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases

Country Status (32)

Country Link
US (1) US8183246B2 (pt)
EP (1) EP1966217B1 (pt)
JP (1) JP5254032B2 (pt)
KR (1) KR101429777B1 (pt)
CN (1) CN101384603B (pt)
AR (1) AR058108A1 (pt)
AU (1) AU2006334856B2 (pt)
BR (1) BRPI0620317A2 (pt)
CA (1) CA2633701C (pt)
CR (1) CR10092A (pt)
DE (1) DE102005061170A1 (pt)
DK (1) DK1966217T3 (pt)
DO (1) DOP2006000280A (pt)
EC (1) ECSP088569A (pt)
ES (1) ES2418855T3 (pt)
GT (1) GT200800117A (pt)
HK (1) HK1130054A1 (pt)
IL (1) IL192062A0 (pt)
MA (1) MA30039B1 (pt)
NO (1) NO20082986L (pt)
NZ (1) NZ569214A (pt)
PE (1) PE20071168A1 (pt)
PL (1) PL1966217T3 (pt)
PT (1) PT1966217E (pt)
RU (1) RU2454419C2 (pt)
SV (1) SV2009002953A (pt)
TN (1) TNSN08279A1 (pt)
TW (1) TWI405764B (pt)
UA (1) UA94080C2 (pt)
UY (1) UY30046A1 (pt)
WO (1) WO2007079862A1 (pt)
ZA (1) ZA200805385B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007019691A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007051762A1 (de) 2007-10-30 2009-05-07 Bayer Healthcare Ag Substituierte Pyrrolotriazine und ihre Verwendung
DE102007054786A1 (de) 2007-11-16 2009-05-20 Bayer Healthcare Ag Trisubstituierte Furopyrimidine und ihre Verwendung
WO2013168760A1 (ja) 2012-05-10 2013-11-14 武田薬品工業株式会社 芳香環化合物
EP2848621A4 (en) 2012-05-10 2016-06-01 Takeda Pharmaceutical AROMATIC CYCLIC COMPOUND
CA3120971A1 (en) 2017-11-27 2019-05-31 Dart Neuroscience, Llc Substituted furanopyrimidine compounds as pde1 inhibitors
SG11202111327XA (en) * 2019-05-13 2021-11-29 Relay Therapeutics Inc Fgfr inhibitors and methods of use thereof
KR102094337B1 (ko) 2019-10-01 2020-03-27 안문호 금속이물질 제거장치

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577420A (en) * 1968-01-05 1971-05-04 Pfizer Certain 4-aminofuro(2,3-d)pyrimidines
DE69917201T2 (de) 1998-07-22 2005-05-04 Daiichi Suntory Pharma Co., Ltd. Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
WO2000075145A1 (en) 1999-06-03 2000-12-14 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CA2350992C (en) 1999-09-17 2009-06-23 Suntory Limited Preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising nf-kb inhibitors as active ingredients
DK1390371T3 (da) 2001-05-14 2006-06-19 Novartis Ag Oxazolo- og furopyrimidiner samt deres anvendelse i lægemidler mod tumorer
DE10141212A1 (de) 2001-08-22 2003-03-06 Bayer Ag Neue 4-Aminofuropyrimidine und ihre Verwendung
US7427623B2 (en) 2001-09-11 2008-09-23 Smithkline Beecham Corporation 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
US20030225098A1 (en) * 2002-03-21 2003-12-04 Hirst Gavin C. Kinase inhibitors
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
KR20070055486A (ko) 2004-06-10 2007-05-30 젠션 디스커버리 리미티드 포타슘 채널 억제제로서 유효한 퓨라노피리미딘 화합물
JP2008505084A (ja) * 2004-06-29 2008-02-21 アムゲン インコーポレイティッド フラノピリミジン

Also Published As

Publication number Publication date
JP5254032B2 (ja) 2013-08-07
AR058108A1 (es) 2008-01-23
US8183246B2 (en) 2012-05-22
BRPI0620317A2 (pt) 2011-11-08
TW200745132A (en) 2007-12-16
DK1966217T3 (da) 2013-08-05
KR20080081323A (ko) 2008-09-09
EP1966217B1 (de) 2013-05-08
CN101384603B (zh) 2012-08-01
TWI405764B (zh) 2013-08-21
DE102005061170A1 (de) 2007-07-05
RU2454419C2 (ru) 2012-06-27
HK1130054A1 (en) 2009-12-18
IL192062A0 (en) 2008-12-29
JP2009520713A (ja) 2009-05-28
ES2418855T3 (es) 2013-08-16
PT1966217E (pt) 2013-07-12
PE20071168A1 (es) 2008-02-07
WO2007079862A1 (de) 2007-07-19
RU2008129363A (ru) 2010-01-27
KR101429777B1 (ko) 2014-08-19
US20090318475A1 (en) 2009-12-24
GT200800117A (es) 2009-12-16
NO20082986L (no) 2008-07-02
PL1966217T3 (pl) 2013-09-30
CR10092A (es) 2008-10-08
UY30046A1 (es) 2007-07-31
TNSN08279A1 (en) 2009-10-30
ECSP088569A (es) 2008-08-29
AU2006334856B2 (en) 2013-04-04
MA30039B1 (fr) 2008-12-01
CN101384603A (zh) 2009-03-11
AU2006334856A1 (en) 2007-07-19
EP1966217A1 (de) 2008-09-10
CA2633701C (en) 2014-05-27
CA2633701A1 (en) 2007-07-19
DOP2006000280A (es) 2007-07-31
UA94080C2 (ru) 2011-04-11
SV2009002953A (es) 2009-04-28
NZ569214A (en) 2011-07-29

Similar Documents

Publication Publication Date Title
ZA200805385B (en) Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
IL179424A0 (en) Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
GB0525041D0 (en) Methods, assays and compositions for treating retinol-related diseases
PL1928882T3 (pl) (S)-N-Metylonaltrekson, sposoby jego syntezy i jego zastosowania farmaceutyczne
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL191655A0 (en) Novel compounds, their preparation and use
HK1105966A1 (en) New 4-benzylidene-piperidin derivatives
IL177204A0 (en) Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
HK1101638A1 (en) New pyridothienopyrimidine derivatives
IL184314A0 (en) Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
IL179068A0 (en) Substituted enaminones, their derivatives and uses thereof
IL183141A0 (en) New pyridothienopyrimidine derivatives
SI2020410T1 (sl) Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
IL177662A0 (en) Novel pyrrolidine-3,4-dicarboxamide derivatives
TWI367222B (en) Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
IL190045A0 (en) Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents
EP1781678A4 (en) 1 -? - HALOGEN-2,2-DIFLUOR-2-DESOXY-D-RIBOFURANOSEDERIVATE AND PROCESS FOR THE PRODUCTION THEREOF
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents